Carisma Therapeutics
CARM
CARM
106 hedge funds and large institutions have $305M invested in Carisma Therapeutics in 2021 Q2 according to their latest regulatory filings, with 43 funds opening new positions, 31 increasing their positions, 21 reducing their positions, and 13 closing their positions.
Holders
106
Holders Change
+30
Holders Change %
+39.47%
% of All Funds
1.85%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
43
Increased
31
Reduced
21
Closed
13
Calls
$6.74M
Puts
$4.96M
Net Calls
+$1.79M
Net Calls Change
+$2.4M
Top Buyers
1 |
1
State Street
Boston,
Massachusetts
|
$63.2M |
2 |
2
BlackRock
New York
|
$49.2M |
3 |
3
Geode Capital Management
Boston,
Massachusetts
|
$13.2M |
4 |
4
Northern Trust
Chicago,
Illinois
|
$7.79M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$39.3M |